AN ACTIVE ANALOG OF INACTIVE SLEEP PEPTIDE

被引：0
|
作者：
KOVALZON, VM [1 ]
KALIKHEVICH, VN [1 ]
CHURKINA, SI [1 ]
机构：
[1] AA ZHDANOV STATE UNIV,FAC CHEM,DEPT NAT CPDS CHEM,LENINGRAD B-164,USSR
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 1986年 / 101卷 / 06期
关键词：
D O I：
10.1007/BF00839607
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：789 / 791
页数：3
相关论文
共 50 条
  • [1] THE USE OF SLEEP ACTIGRAPHY DIFFERENTIATES SLEEP DISTURBANCES IN ACTIVE AND INACTIVE CROHN'S DISEASE
    Qazi, Taha
    Verma, Rashmi
    Hamilton, Matthew
    Kaplan, Emily
    Redline, Susan
    Burakoff, Robert
    GASTROENTEROLOGY, 2018, 154 (06) : S813 - S813
  • [2] TO BE ACTIVE OR NOT TO BE INACTIVE
    Notthoff, N.
    Carstensen, L.
    GERONTOLOGIST, 2009, 49 : 446 - 446
  • [3] The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease
    Qazi, Taha
    Verma, Rashmi
    Hamilton, Matthew J.
    Kaplan, Emily R.
    Redline, Susan
    Burakoff, Robert
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (06) : 1044 - 1053
  • [4] Antimicrobial and conformational studies of the active and inactive analogues of the protegrin-1 peptide
    Rodziewicz-Motowidlo, Sylwia
    Mickiewicz, Beata
    Greber, Katarzyna
    Sikorska, Emilia
    Szultka, Lukasz
    Kamysz, Elzbieta
    Kamysz, Wojciech
    FEBS JOURNAL, 2010, 277 (04) : 1010 - 1022
  • [5] Conversed mutagenesis of an inactive peptide to ASIC3 inhibitor for active sites determination
    Osmakov, Dmitry I.
    Koshelev, Sergey G.
    Andreev, Yaroslav A.
    Dyachenko, Igor A.
    Bondarenko, Dmitry A.
    Murashev, Arkadii N.
    Grishin, Eugene V.
    Kozlov, Sergey A.
    TOXICON, 2016, 116 : 11 - 16
  • [6] ACTIVE AND INACTIVE SITES
    不详
    NATURE, 1969, 221 (5185) : 1003 - &
  • [7] Development of an Active Site Peptide Analog of α-Fetoprotein That Prevents Breast Cancer
    Jacobson, Herbert I.
    Andersen, Thomas T.
    Bennett, James A.
    CANCER PREVENTION RESEARCH, 2014, 7 (06) : 565 - 573
  • [8] Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatography
    Wu, P
    Stenman, UH
    Pakkala, M
    Närvänen, A
    Leinonen, J
    PROSTATE, 2004, 58 (04): : 345 - 353
  • [9] Opioid peptide analog design: From cyclic enkephalins to orally active analgesics
    Schiller, PW
    BIOPOLYMERS, 2005, 80 (04) : 492 - 492
  • [10] ACTIVE AND INACTIVE RENIN IN THE CAT
    MCKENZIE, IM
    HEIMAN, D
    MCKENZIE, JK
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1987, 9 (10) : 1637 - 1658
12345